Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by Kensin1953on May 10, 2019 11:10am

112 Views

Post# 29734219

RE:Analyst estimates Q2, Q3

This is the important information. Where will LABS be in 12 months.

Margins will come around and with these numbers good profits.

TRUMP is messing with the markets short term so a segment of U.S. investors are likely pulling profits on his Pro-American stance going into the weekend.

JMHO

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario